| NCT04430842 |
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S |
https://ClinicalTrials.gov/show/NCT04430842 |
Recruiting |
Quadriga Biosciences, Inc. |
2021-09-30 |
| NCT04166409 |
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma |
https://ClinicalTrials.gov/show/NCT04166409 |
Recruiting |
National Cancer Institute (NCI) |
2026-12-31 |
| NCT03919071 |
Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma |
https://ClinicalTrials.gov/show/NCT03919071 |
Recruiting |
National Cancer Institute (NCI) |
2022-06-01 |
| NCT03355794 |
A Study of Ribociclib and Everolimus Following Radiation Therapy in Children With Newly Diagnosed Non-biopsied Diffuse Pontine Gliomas (DIPG) and RB+ Biopsied DIPG and High Grade Gliomas (HGG) |
https://ClinicalTrials.gov/show/NCT03355794 |
Active, not recruiting |
Children’s Hospital Medical Center, Cincinnati |
2020-07-01 |
| NCT03332355 |
Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 2 |
https://ClinicalTrials.gov/show/NCT03332355 |
Recruiting |
Vanquish Oncology, Inc. |
2019-12-30 |
| NCT03243461 |
International Cooperative Phase III Trial of the HIT-HGG Study Group (HIT-HGG-2013) |
https://ClinicalTrials.gov/show/NCT03243461 |
Recruiting |
University of Göttingen |
2022-01-01 |
| NCT03224104 |
Study of TG02 in Elderly Newly Diagnosed or Adult Relapsed Patients With Anaplastic Astrocytoma or Glioblastoma |
https://ClinicalTrials.gov/show/NCT03224104 |
Recruiting |
European Organisation for Research and Treatment of Cancer - EORTC |
2020-08-31 |
| NCT03180502 |
Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma |
https://ClinicalTrials.gov/show/NCT03180502 |
Recruiting |
NRG Oncology |
2025-01-31 |
| NCT03152318 |
A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2 |
https://ClinicalTrials.gov/show/NCT03152318 |
Recruiting |
Dana-Farber Cancer Institute |
2021-07-31 |
| NCT03072134 |
Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant Glioma |
https://ClinicalTrials.gov/show/NCT03072134 |
Completed |
Northwestern University |
2020-04-06 |
| NCT03043391 |
Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children |
https://ClinicalTrials.gov/show/NCT03043391 |
Recruiting |
Istari Oncology, Inc. |
2020-07-01 |
| NCT03032484 |
TVB- 2640 in Combination With Bevacizumab in Patients With First Relapse of High Grade Astrocytoma |
https://ClinicalTrials.gov/show/NCT03032484 |
Active, not recruiting |
The University of Texas Health Science Center at San Antonio |
2021-04-10 |
| NCT03027388 |
Protein Phosphatase 2A Inhibitor, in Recurrent Glioblastoma |
https://ClinicalTrials.gov/show/NCT03027388 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2021-08-30 |
| NCT03022578 |
Laser Interstitial Thermal Therapy and Lomustine in Treating Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma |
https://ClinicalTrials.gov/show/NCT03022578 |
Recruiting |
M.D. Anderson Cancer Center |
2021-11-01 |
| NCT03020602 |
BPM31510 in Treating Patients With Recurrent High-Grade Glioma Previously Treated With Bevacizumab |
https://ClinicalTrials.gov/show/NCT03020602 |
Active, not recruiting |
Stanford University |
2019-04-04 |
| NCT02924038 |
A Study of Varlilumab and IMA950 Vaccine Plus Poly-ICLC in Patients With WHO Grade II Low-Grade Glioma (LGG) |
https://ClinicalTrials.gov/show/NCT02924038 |
Recruiting |
University of California, San Francisco |
2021-06-30 |
| NCT02903784 |
Neural Basis of Language Processing |
https://ClinicalTrials.gov/show/NCT02903784 |
Completed |
University Hospital, Montpellier |
2015-02-28 |
| NCT02885324 |
Pilot Study of Cabozantinib for Recurrent or Progressive High-Grade Glioma in Children |
https://ClinicalTrials.gov/show/NCT02885324 |
Recruiting |
Indiana University |
2021-07-31 |
| NCT02858895 |
Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive Glioblastoma |
https://ClinicalTrials.gov/show/NCT02858895 |
Completed |
Medicenna Therapeutics, Inc. |
2019-09-12 |
| NCT02796261 |
Study to Evaluate Eflornithine + Lomustine vs Lomustine in Recurrent Anaplastic Astrocytoma (AA) Patients |
https://ClinicalTrials.gov/show/NCT02796261 |
Recruiting |
Orbus Therapeutics, Inc. |
2020-06-30 |
| NCT02766699 |
A Study to Evaluate the Safety, Tolerability and Immunogenicity of EGFR(V)-EDV-Dox in Subjects With Recurrent Glioblastoma Multiforme (GBM) |
https://ClinicalTrials.gov/show/NCT02766699 |
Recruiting |
Engeneic Pty Limited |
2019-12-31 |
| NCT02758366 |
Prolonged Exposure to Doxorubicin in Patients With Glioblastoma Multiforme and Diffuse Intrinsic Pontine Glioma |
https://ClinicalTrials.gov/show/NCT02758366 |
Recruiting |
Meyer Children’s Hospital |
2020-07-31 |
| NCT02722512 |
Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine |
https://ClinicalTrials.gov/show/NCT02722512 |
Recruiting |
Ann & Robert H Lurie Children’s Hospital of Chicago |
2019-05-31 |
| NCT02644291 |
Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors |
https://ClinicalTrials.gov/show/NCT02644291 |
Recruiting |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2021-06-30 |
| NCT02629757 |
A Study on β-elemene as Maintain Treatment for Newly Diagnosed Malignant Gliomas |
https://ClinicalTrials.gov/show/NCT02629757 |
Recruiting |
Sun Yat-sen University |
2020-04-30 |
| NCT01331135 |
Aflac ST0901 CHOANOME - Sirolimus in Solid Tumors |
https://ClinicalTrials.gov/show/NCT01331135 |
Completed |
Emory University |
2017-08-09 |
| NCT02942264 |
Zotiraciclib (TG02) Plus Dose-Dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of Zotiraciclib (TG02) Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and Glioblastoma |
https://ClinicalTrials.gov/show/NCT02942264 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2021-08-02 |
| NCT02023905 |
Everolimus With and Without Temozolomide in Adult Low Grade Glioma |
https://ClinicalTrials.gov/show/NCT02023905 |
Active, not recruiting |
University of California, San Francisco |
2021-09-30 |
| NCT01189266 |
Vorinostat and Radiation Therapy Followed by Maintenance Therapy With Vorinostat in Treating Younger Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma |
https://ClinicalTrials.gov/show/NCT01189266 |
Active, not recruiting |
National Cancer Institute (NCI) |
2017-06-30 |
| NCT03389802 |
Phase I Study of APX005M in Pediatric CNS Tumors |
https://ClinicalTrials.gov/show/NCT03389802 |
Recruiting |
Pediatric Brain Tumor Consortium |
2020-09-30 |
| NCT02529072 |
Nivolumab With DC Vaccines for Recurrent Brain Tumors |
https://ClinicalTrials.gov/show/NCT02529072 |
Completed |
Duke University |
2017-09-15 |
| NCT02490930 |
A Safety Study of Fingolimod With Radiation and Temozolomide in Newly Diagnosed High Grade Glioma |
https://ClinicalTrials.gov/show/NCT02490930 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2017-09-30 |
| NCT02444546 |
Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or Refractory Brain Tumors |
https://ClinicalTrials.gov/show/NCT02444546 |
Active, not recruiting |
Mayo Clinic |
2018-07-13 |
| NCT02372409 |
Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors |
https://ClinicalTrials.gov/show/NCT02372409 |
Recruiting |
Washington University School of Medicine |
2021-10-30 |
| NCT02366728 |
DC Migration Study for Newly-Diagnosed GBM |
https://ClinicalTrials.gov/show/NCT02366728 |
Active, not recruiting |
Duke University |
2020-08-31 |
| NCT02343224 |
Pegylated Interferon ALFA-2b in Children With Juvenile Pilocytic Astrocytomas and Optic Pathway Gliomas |
https://ClinicalTrials.gov/show/NCT02343224 |
Recruiting |
Emory University |
2021-12-31 |
| NCT02209428 |
A Prospective Cohort to Study the Effect of Temozolomide on IDH Mutational Low Grade Gliomas |
https://ClinicalTrials.gov/show/NCT02209428 |
Active, not recruiting |
Huashan Hospital |
2019-04-30 |
| NCT02192359 |
Carboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas |
https://ClinicalTrials.gov/show/NCT02192359 |
Recruiting |
City of Hope Medical Center |
2021-03-07 |
| NCT02186509 |
Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas |
https://ClinicalTrials.gov/show/NCT02186509 |
Completed |
Thomas Jefferson University |
2017-03-31 |
| NCT02101905 |
Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma |
https://ClinicalTrials.gov/show/NCT02101905 |
Active, not recruiting |
National Cancer Institute (NCI) |
2019-12-31 |
| NCT02077543 |
Multicenter Safety Trial Assessing an Innovative Tumor Molecular and Cellular Print Medical Device in Glioma |
https://ClinicalTrials.gov/show/NCT02077543 |
Recruiting |
University Hospital, Grenoble |
2020-06-30 |
| NCT02062827 |
Genetically Engineered HSV-1 Phase 1 Study for the Treatment of Recurrent Malignant Glioma |
https://ClinicalTrials.gov/show/NCT02062827 |
Recruiting |
University of Alabama at Birmingham |
2021-09-30 |
| NCT01316809 |
AZD8055 for Adults With Recurrent Gliomas |
https://ClinicalTrials.gov/show/NCT01316809 |
Completed |
National Institutes of Health Clinical Center (CC) |
2014-04-14 |
| NCT01290692 |
Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma |
https://ClinicalTrials.gov/show/NCT01290692 |
Completed |
TVAX Biomedical |
2013-12-31 |
| NCT01288235 |
Proton Radiotherapy for Pediatric Brain Tumors Requiring Partial Brain Irradiation |
https://ClinicalTrials.gov/show/NCT01288235 |
Active, not recruiting |
Massachusetts General Hospital |
2022-09-30 |
| NCT01269853 |
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA |
https://ClinicalTrials.gov/show/NCT01269853 |
Recruiting |
Northwell Health |
2020-10-31 |
| NCT02015819 |
Genetically Modified Neural Stem Cells, Flucytosine, and Leucovorin for Treating Patients With Recurrent High-Grade Gliomas |
https://ClinicalTrials.gov/show/NCT02015819 |
Active, not recruiting |
City of Hope Medical Center |
2019-06-30 |
| NCT02010606 |
Phase I Study of a Dendritic Cell Vaccine for Patients With Either Newly Diagnosed or Recurrent Glioblastoma |
https://ClinicalTrials.gov/show/NCT02010606 |
Active, not recruiting |
Cedars-Sinai Medical Center |
2020-10-31 |
| NCT01999270 |
Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS Tumors |
https://ClinicalTrials.gov/show/NCT01999270 |
Completed |
Washington University School of Medicine |
2016-05-31 |
| NCT01985256 |
Study of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brain Tumor |
https://ClinicalTrials.gov/show/NCT01985256 |
Completed |
Tocagen Inc. |
2016-03-03 |
| NCT01975116 |
p28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System Tumors |
https://ClinicalTrials.gov/show/NCT01975116 |
Completed |
Pediatric Brain Tumor Consortium |
2015-04-30 |
| NCT01967758 |
Phase I Study of Safety and Immunogenicity of ADU-623 |
https://ClinicalTrials.gov/show/NCT01967758 |
Completed |
Providence Health & Services |
2018-06-18 |
| NCT01922076 |
Adavosertib and Local Radiation Therapy in Treating Children With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas |
https://ClinicalTrials.gov/show/NCT01922076 |
Active, not recruiting |
National Cancer Institute (NCI) |
2021-10-31 |
| NCT01884740 |
Intraarterial Infusion Of Erbitux and Bevacizumab For Relapsed/Refractory Intracranial Glioma In Patients Under 22 |
https://ClinicalTrials.gov/show/NCT01884740 |
Recruiting |
Weill Medical College of Cornell University |
2025-01-31 |
| NCT01837862 |
A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas |
https://ClinicalTrials.gov/show/NCT01837862 |
Recruiting |
Northwell Health |
2020-04-30 |
| NCT01833273 |
Dose Evaluation Safety STudy IN Individuals With Astrocytoma Taking PolyMVA |
https://ClinicalTrials.gov/show/NCT01833273 |
Completed |
Stony Brook University |
2013-10-31 |
| NCT01808820 |
Dendritic Cell (DC) Vaccine for Malignant Glioma and Glioblastoma |
https://ClinicalTrials.gov/show/NCT01808820 |
Active, not recruiting |
University of Miami |
2018-11-02 |
| NCT01700569 |
Phase-1 Study of Folinic Acid to Modulate MGMT Gene in Glioblastoma |
https://ClinicalTrials.gov/show/NCT01700569 |
Recruiting |
Institut Cancerologie de l’Ouest |
2020-09-30 |
| NCT01663012 |
Phase II NKTR-102 In Bevacizumab-Resistant High Grade Glioma |
https://ClinicalTrials.gov/show/NCT01663012 |
Completed |
Stanford University |
2015-02-28 |
| NCT01649830 |
Efficacy of Post-radiation Adjuvant Temozolomide Chemotherapy in Residue Low-grade Glioma |
https://ClinicalTrials.gov/show/NCT01649830 |
Recruiting |
Sun Yat-sen University |
2025-08-31 |
| NCT01648348 |
Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme |
https://ClinicalTrials.gov/show/NCT01648348 |
Completed |
National Cancer Institute (NCI) |
2016-05-11 |
| NCT01644955 |
Carboplatin in Treating Patients With Recurrent High-Grade Gliomas |
https://ClinicalTrials.gov/show/NCT01644955 |
Completed |
Ohio State University Comprehensive Cancer Center |
2017-12-08 |
| NCT01553149 |
Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma |
https://ClinicalTrials.gov/show/NCT01553149 |
Active, not recruiting |
National Cancer Institute (NCI) |
2020-06-30 |
| NCT01522820 |
Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors |
https://ClinicalTrials.gov/show/NCT01522820 |
Completed |
Roswell Park Cancer Institute |
2016-07-31 |
| NCT01514201 |
Veliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine Gliomas |
https://ClinicalTrials.gov/show/NCT01514201 |
Completed |
National Cancer Institute (NCI) |
2018-03-28 |
| NCT01502241 |
Phase III Trial of Primary Radio- or Chemotherapy in Malignant Astrocytoma of the Elderly |
https://ClinicalTrials.gov/show/NCT01502241 |
Completed |
Heidelberg University |
2010-11-30 |
| NCT01475006 |
AMG 595 First-in-Human in Recurrent Gliomas |
https://ClinicalTrials.gov/show/NCT01475006 |
Completed |
Amgen |
2016-04-30 |
| NCT01470794 |
Study of a Retroviral Replicating Vector Combined With a Prodrug to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor |
https://ClinicalTrials.gov/show/NCT01470794 |
Completed |
Tocagen Inc. |
2016-04-12 |
| NCT01462695 |
Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma |
https://ClinicalTrials.gov/show/NCT01462695 |
Completed |
National Cancer Institute (NCI) |
2013-12-31 |
| NCT01392209 |
Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant Glioma |
https://ClinicalTrials.gov/show/NCT01392209 |
Completed |
Memorial Sloan Kettering Cancer Center |
2019-11-15 |
| NCT01380782 |
BIBF 1120 for Recurrent High-Grade Gliomas |
https://ClinicalTrials.gov/show/NCT01380782 |
Completed |
Dana-Farber Cancer Institute |
2013-07-31 |
| NCT04295759 |
INCB7839 in Treating Children With Recurrent/Progressive High-Grade Gliomas |
https://ClinicalTrials.gov/show/NCT04295759 |
Recruiting |
Pediatric Brain Tumor Consortium |
2022-03-31 |
| NCT04197934 |
WSD0922-FU for the Treatment of Glioblastoma, Anaplastic Astrocytoma, or Non-small Cell Lung Cancer With Central Nervous System Metastases |
https://ClinicalTrials.gov/show/NCT04197934 |
Recruiting |
Mayo Clinic |
2022-12-20 |
| NCT04135807 |
Implantable Microdevice In Primary Brain Tumors |
https://ClinicalTrials.gov/show/NCT04135807 |
Recruiting |
Dana-Farber Cancer Institute |
2021-01-21 |
| NCT04065776 |
Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma |
https://ClinicalTrials.gov/show/NCT04065776 |
Recruiting |
St. Jude Children’s Research Hospital |
2023-05-31 |
| NCT03975829 |
Pediatric Long-Term Follow-up and Rollover Study |
https://ClinicalTrials.gov/show/NCT03975829 |
Recruiting |
Novartis |
2022-12-23 |
| NCT03956706 |
Study of Stereotactic Radiosurgery to the Subventricular Zone in Malignant Gliomas |
https://ClinicalTrials.gov/show/NCT03956706 |
Recruiting |
Northwell Health |
2021-06-30 |
| NCT03896568 |
Oncolytic Adenovirus DNX-2401 in Treating Patients With Recurrent High-Grade Glioma |
https://ClinicalTrials.gov/show/NCT03896568 |
Recruiting |
M.D. Anderson Cancer Center |
2020-02-28 |
| NCT03893487 |
Fimepinostat in Treating Brain Tumors in Children and Young Adults |
https://ClinicalTrials.gov/show/NCT03893487 |
Recruiting |
University of California, San Francisco |
2022-06-01 |
| NCT03796273 |
Ketoconazole Before Surgery in Treating Patients With Recurrent Glioma or Breast Cancer Brain Metastases |
https://ClinicalTrials.gov/show/NCT03796273 |
Recruiting |
Wake Forest University Health Sciences |
2021-02-01 |
| NCT03739372 |
Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade Glioma |
https://ClinicalTrials.gov/show/NCT03739372 |
Recruiting |
University of California, San Francisco |
2020-11-01 |
| NCT03657576 |
Trial of C134 in Patients With Recurrent GBM |
https://ClinicalTrials.gov/show/NCT03657576 |
Recruiting |
University of Alabama at Birmingham |
2022-09-30 |
| NCT03633552 |
Efficacy of Two Temozolomide Regimens in Adjuvant Treatment of Patients With Brain High Grade Glioma |
https://ClinicalTrials.gov/show/NCT03633552 |
Recruiting |
Mashhad University of Medical Sciences |
2021-03-03 |
| NCT03603405 |
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM |
https://ClinicalTrials.gov/show/NCT03603405 |
Recruiting |
The Methodist Hospital System |
2023-12-31 |
| NCT03596086 |
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM |
https://ClinicalTrials.gov/show/NCT03596086 |
Recruiting |
The Methodist Hospital System |
2023-12-30 |
| NCT03581292 |
Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 Mutations |
https://ClinicalTrials.gov/show/NCT03581292 |
Recruiting |
National Cancer Institute (NCI) |
2024-10-29 |
| NCT03528642 |
CB-839 With Radiation Therapy and Temozolomide in Treating Participants With IDH-Mutated Diffuse Astrocytoma or Anaplastic Astrocytoma |
https://ClinicalTrials.gov/show/NCT03528642 |
Recruiting |
National Cancer Institute (NCI) |
2022-12-05 |
| NCT03450850 |
Study Of NOVOTTF-200A In Bevacizumab-Naive Subjects With Recurrent Grade III Malignant Astrocytoma |
https://ClinicalTrials.gov/show/NCT03450850 |
Recruiting |
University of California, Irvine |
2023-06-30 |
| NCT03434262 |
SJDAWN: St. Jude Children’s Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors |
https://ClinicalTrials.gov/show/NCT03434262 |
Recruiting |
St. Jude Children’s Research Hospital |
2025-02-28 |
| NCT01250470 |
Vaccine Therapy and Sargramostim in Treating Patients With Malignant Glioma |
https://ClinicalTrials.gov/show/NCT01250470 |
Completed |
Roswell Park Cancer Institute |
2014-05-29 |
| NCT01240460 |
Exploratory Study of XL765 (SAR245409) or XL147 (SAR245408) in Subjects With Recurrent Glioblastoma Who Are Candidates for Surgical Resection |
https://ClinicalTrials.gov/show/NCT01240460 |
Completed |
Sanofi |
2012-06-30 |
| NCT01238237 |
Super-Selective Intraarterial Cerebral Infusion of Cetuximab (Erbitux) for Treatment of Relapsed/Refractory GBM and AA |
https://ClinicalTrials.gov/show/NCT01238237 |
Completed |
Northwell Health |
2016-01-31 |
| NCT01236560 |
Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade Glioma |
https://ClinicalTrials.gov/show/NCT01236560 |
Active, not recruiting |
National Cancer Institute (NCI) |
2016-09-27 |
| NCT01234740 |
Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases |
https://ClinicalTrials.gov/show/NCT01234740 |
Completed |
City of Hope Medical Center |
2013-03-31 |
| NCT01222754 |
Lenalidomide and Radiation Therapy in High Grade Gliomas or Diffuse Intrinsic Pontine Gliomas |
https://ClinicalTrials.gov/show/NCT01222754 |
Completed |
National Institutes of Health Clinical Center (CC) |
2019-04-17 |
| NCT01204684 |
Dendritic Cell Vaccine for Patients With Brain Tumors |
https://ClinicalTrials.gov/show/NCT01204684 |
Active, not recruiting |
Jonsson Comprehensive Cancer Center |
2021-01-31 |
| NCT01180816 |
Super-Selective Intraarterial Cerebral Infusion Of Temozolomide (Temodar) For Treatment Of Newly Diagnosed GBM And AA |
https://ClinicalTrials.gov/show/NCT01180816 |
Active, not recruiting |
Northwell Health |
2017-12-31 |
| NCT01171469 |
Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor |
https://ClinicalTrials.gov/show/NCT01171469 |
Completed |
Masonic Cancer Center, University of Minnesota |
2012-05-31 |
| NCT01165632 |
Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma |
https://ClinicalTrials.gov/show/NCT01165632 |
Active, not recruiting |
Mayo Clinic |
2013-11-01 |
| NCT01156584 |
A Study of a Retroviral Replicating Vector Combined With a Prodrug Administered to Patients With Recurrent Malignant Glioma |
https://ClinicalTrials.gov/show/NCT01156584 |
Completed |
Tocagen Inc. |
2016-08-18 |
| NCT01151670 |
Pioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Treating Patients With Brain Tumors |
https://ClinicalTrials.gov/show/NCT01151670 |
Completed |
Wake Forest University Health Sciences |
2014-08-31 |
| NCT01144247 |
Cellular Immunotherapy Study for Brain Cancer |
https://ClinicalTrials.gov/show/NCT01144247 |
Completed |
Jonsson Comprehensive Cancer Center |
2015-07-31 |
| NCT01131234 |
Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT01131234 |
Completed |
National Cancer Institute (NCI) |
2014-09-30 |
| NCT01125800 |
A Phase I Dose Finding and Safety Study of Oral LDE225 in Children and a Phase II Portion to Assess Preliminary Efficacy in Recurrent or Refractory MB |
https://ClinicalTrials.gov/show/NCT01125800 |
Completed |
Novartis |
2014-10-31 |
| NCT01119599 |
RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma |
https://ClinicalTrials.gov/show/NCT01119599 |
Completed |
National Cancer Institute (NCI) |
2013-06-30 |
| NCT01089101 |
Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma |
https://ClinicalTrials.gov/show/NCT01089101 |
Recruiting |
National Cancer Institute (NCI) |
2022-12-31 |
| NCT01082926 |
Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2 |
https://ClinicalTrials.gov/show/NCT01082926 |
Completed |
City of Hope Medical Center |
2013-09-30 |
| NCT01081223 |
Phase I/II Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma |
https://ClinicalTrials.gov/show/NCT01081223 |
Completed |
TVAX Biomedical |
2011-03-31 |
| NCT01076530 |
Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors |
https://ClinicalTrials.gov/show/NCT01076530 |
Completed |
National Cancer Institute (NCI) |
2012-10-31 |
| NCT01068782 |
Study of Multiple Doses and Regimens of XL184 (Cabozantinib) in Subjects With Grade IV Astrocytic Tumors in First or Second Relapse |
https://ClinicalTrials.gov/show/NCT01068782 |
Completed |
Exelixis |
2011-05-31 |
| NCT01024907 |
Proton Beam Radiation Therapy in Treating Patients With Low Grade Gliomas |
https://ClinicalTrials.gov/show/NCT01024907 |
Completed |
Abramson Cancer Center of the University of Pennsylvania |
2014-02-28 |
| NCT01012609 |
External Beam Radiation Therapy and Cetuximab Followed by Irinotecan and Cetuximab for Children and Young Adults With Newly Diagnosed Diffuse Pontine Tumors and High-Grade Astrocytomas |
https://ClinicalTrials.gov/show/NCT01012609 |
Active, not recruiting |
Memorial Sloan Kettering Cancer Center |
2020-11-30 |
| NCT00995007 |
A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade Gliomas |
https://ClinicalTrials.gov/show/NCT00995007 |
Completed |
National Institutes of Health Clinical Center (CC) |
2015-06-30 |
| NCT00994500 |
Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma |
https://ClinicalTrials.gov/show/NCT00994500 |
Completed |
National Cancer Institute (NCI) |
2011-07-31 |
| NCT00994071 |
A Phase I Study of ABT-888, an Oral Inhibitor of Poly(ADP-ribose) Polymerase and Temozolomide in Children With Recurrent/Refractory CNS Tumors |
https://ClinicalTrials.gov/show/NCT00994071 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00968240 |
Super-Selective Intraarterial Intracranial Infusion of Avastin (Bevacizumab) |
https://ClinicalTrials.gov/show/NCT00968240 |
Completed |
Northwell Health |
2014-01-31 |
| NCT00946335 |
ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors |
https://ClinicalTrials.gov/show/NCT00946335 |
Completed |
National Cancer Institute (NCI) |
2011-10-31 |
| NCT00921167 |
A Study to Evaluate the Efficacy of Bevacizumab Plus Irinotecan in Recurrent Gliomas |
https://ClinicalTrials.gov/show/NCT00921167 |
Completed |
Clinical Research Center for Solid Tumor, Korea |
2012-06-30 |
| NCT00884416 |
Sorafenib in Newly Diagnosed High Grade Glioma |
https://ClinicalTrials.gov/show/NCT00884416 |
Completed |
University Hospital, Geneva |
2011-12-31 |
| NCT00879437 |
Valproic Acid and Radiation Followed by Maintenance Valproic Acid and Bevacizumab in Children With High Grade Gliomas or Diffuse Intrinsic Pontine Glioma |
https://ClinicalTrials.gov/show/NCT00879437 |
Active, not recruiting |
Baylor College of Medicine |
2020-06-30 |
| NCT00874861 |
HLA-A2-Restricted Glioma Antigen-Peptides Vaccinations With Poly-ICLC for Recurrent WHO Grade II Gliomas |
https://ClinicalTrials.gov/show/NCT00874861 |
Completed |
University of Pittsburgh |
2012-05-31 |
| NCT00841555 |
Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic Astrocytoma |
https://ClinicalTrials.gov/show/NCT00841555 |
Completed |
Ohio State University Comprehensive Cancer Center |
2013-02-13 |
| NCT03861299 |
The SAFE-Trial: Awake Craniotomy Versus Surgery Under General Anesthesia for Glioblastoma Patients. |
https://ClinicalTrials.gov/show/NCT03861299 |
Recruiting |
Erasmus Medical Center |
2023-03-06 |
| NCT03538587 |
Feasibility and Preliminary Efficacy of a Mindfulness-based Intervention for Children and Young Adults With High Grade or High-Risk Cancer and Their Caregivers |
https://ClinicalTrials.gov/show/NCT03538587 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2021-04-01 |
| NCT02465268 |
Vaccine Therapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme |
https://ClinicalTrials.gov/show/NCT02465268 |
Recruiting |
Immunomic Therapeutics, Inc. |
2023-06-30 |
| NCT00823797 |
Bendamustine Hydrochloride in Treating Patients With Recurrent or Progressive Anaplastic Glioma |
https://ClinicalTrials.gov/show/NCT00823797 |
Completed |
University of Washington |
2015-12-31 |
| NCT00823459 |
Everolimus in Treating Patients With Recurrent Low-Grade Glioma |
https://ClinicalTrials.gov/show/NCT00823459 |
Completed |
University of California, San Francisco |
2017-06-12 |
| NCT02684058 |
Phase II Pediatric Study With Dabrafenib in Combination With Trametinib in Patients With HGG and LGG |
https://ClinicalTrials.gov/show/NCT02684058 |
Recruiting |
Novartis |
2021-11-11 |
| NCT01172964 |
A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas |
https://ClinicalTrials.gov/show/NCT01172964 |
Completed |
City of Hope Medical Center |
2015-02-11 |
| NCT01403610 |
Safety and Efficacy Study of TH-302 CNS Penetration in Recurrent High Grade Astrocytoma Following Bevacizumab |
https://ClinicalTrials.gov/show/NCT01403610 |
Completed |
The University of Texas Health Science Center at San Antonio |
2015-10-31 |
| NCT03911388 |
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors |
https://ClinicalTrials.gov/show/NCT03911388 |
Recruiting |
University of Alabama at Birmingham |
2023-09-01 |
| NCT02709226 |
Dose Escalation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma |
https://ClinicalTrials.gov/show/NCT02709226 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2020-10-30 |
| NCT02549833 |
Neo-adjuvant Evaluation of Glioma Lysate Vaccines in WHO Grade II Glioma |
https://ClinicalTrials.gov/show/NCT02549833 |
Recruiting |
University of California, San Francisco |
2023-06-01 |
| NCT02457845 |
HSV G207 Alone or With a Single Radiation Dose in Children With Progressive or Recurrent Supratentorial Brain Tumors |
https://ClinicalTrials.gov/show/NCT02457845 |
Recruiting |
University of Alabama at Birmingham |
2020-10-31 |
| NCT02800486 |
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA |
https://ClinicalTrials.gov/show/NCT02800486 |
Recruiting |
Northwell Health |
2021-05-31 |
| NCT03973918 |
Study of Binimetinib With Encorafenib in Adults With Recurrent BRAF V600-Mutated HGG |
https://ClinicalTrials.gov/show/NCT03973918 |
Recruiting |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2022-07-31 |
| NCT03971734 |
Determining Dose of Regadenoson Most Likely to Transiently Alter the Integrity of the Blood-Brain Barrier in Patients With High Grade Gliomas |
https://ClinicalTrials.gov/show/NCT03971734 |
Active, not recruiting |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2022-03-31 |
| NCT02238496 |
Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant Gliomas |
https://ClinicalTrials.gov/show/NCT02238496 |
Active, not recruiting |
Columbia University |
2017-10-27 |
| NCT03722355 |
Hyperfractionated RT With BCNU Versus Conventional RT With BCNU for Supratentorial Malignant Glioma |
https://ClinicalTrials.gov/show/NCT03722355 |
Completed |
Radiation Therapy Oncology Group |
1994-03-15 |
| NCT00789828 |
Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1) |
https://ClinicalTrials.gov/show/NCT00789828 |
Completed |
Novartis |
2011-03-31 |
| NCT00783393 |
SCH 52365 Phase II Clinical Study: A Study on the Efficacy and Safety of Monotherapy With SCH 52365 in Patients With First Relapsed Anaplastic Astrocytoma (Study P03745) |
https://ClinicalTrials.gov/show/NCT00783393 |
Completed |
Merck Sharp & Dohme Corp. |
2005-06-17 |
| NCT00782626 |
Everolimus (RAD001) for Children With Chemotherapy-Refractory Progressive or Recurrent Low-Grade Gliomas |
https://ClinicalTrials.gov/show/NCT00782626 |
Completed |
Dana-Farber Cancer Institute |
2012-08-31 |
| NCT00751270 |
Phase 1b Study of AdV-tk + Valacyclovir Combined With Radiation Therapy for Malignant Gliomas |
https://ClinicalTrials.gov/show/NCT00751270 |
Completed |
Advantagene, Inc. |
2010-01-31 |
| NCT00734682 |
A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas |
https://ClinicalTrials.gov/show/NCT00734682 |
Completed |
University of California, San Francisco |
2014-12-31 |
| NCT00717210 |
Randomized Phase III Study of Sequential Radiochemotherapy of Anaplastic Glioma With PCV or Temozolomide |
https://ClinicalTrials.gov/show/NCT00717210 |
Completed |
Neuro-Oncology Working Group of the German Cancer Society |
2005-02-28 |
| NCT00679354 |
Cilengitide in Treating Younger Patients With Recurrent or Progressive High-Grade Glioma That Has Not Responded to Standard Therapy |
https://ClinicalTrials.gov/show/NCT00679354 |
Completed |
National Cancer Institute (NCI) |
2010-10-31 |
| NCT00667394 |
Tandutinib Plus Bevacizumab to Treat Recurrent Brain Tumors |
https://ClinicalTrials.gov/show/NCT00667394 |
Completed |
National Institutes of Health Clinical Center (CC) |
2011-07-31 |
| NCT00650923 |
Aflibercept, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme, Gliosarcoma, or Other Malignant Glioma |
https://ClinicalTrials.gov/show/NCT00650923 |
Completed |
National Cancer Institute (NCI) |
2013-06-30 |
| NCT00638898 |
Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor |
https://ClinicalTrials.gov/show/NCT00638898 |
Active, not recruiting |
City of Hope Medical Center |
2020-09-01 |
| NCT00624728 |
Assessment of 18FLT PET-CT for Volume Definition of High-grade Gliomas (GLIO-TEP) |
https://ClinicalTrials.gov/show/NCT00624728 |
Completed |
University Hospital, Bordeaux |
2011-11-30 |
| NCT00612651 |
PH I Addition of Farnesyl Transferase Inhibitor to Temozolomide for Pts w Gr 3 & 4 Malignant Gliomas |
https://ClinicalTrials.gov/show/NCT00612651 |
Completed |
Duke University |
2009-01-31 |
| NCT00610571 |
Ph I Oral Topotecan and Temozolomide for Patients With Malignant Gliomas |
https://ClinicalTrials.gov/show/NCT00610571 |
Completed |
Duke University |
2009-09-30 |
| NCT00606008 |
A Phase II Trial of Sutent (Sunitinib; SU011248) for Recurrent Anaplastic Astrocytoma and Glioblastoma |
https://ClinicalTrials.gov/show/NCT00606008 |
Completed |
H. Lee Moffitt Cancer Center and Research Institute |
2012-08-31 |
| NCT00589875 |
Phase 2a Study of AdV-tk With Standard Radiation Therapy for Malignant Glioma (BrTK02) |
https://ClinicalTrials.gov/show/NCT00589875 |
Completed |
Advantagene, Inc. |
2015-12-31 |
| NCT00575887 |
Efficacy of Protracted Temozolomide in Patients With Progressive High Grade Glioma |
https://ClinicalTrials.gov/show/NCT00575887 |
Completed |
Marmara University |
2009-03-31 |
| NCT00499473 |
Sunitinib in Treating Patients With Recurrent Malignant Gliomas |
https://ClinicalTrials.gov/show/NCT00499473 |
Completed |
National Cancer Institute (NCI) |
2009-06-30 |
| NCT00492089 |
Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT00492089 |
Completed |
National Cancer Institute (NCI) |
2010-08-31 |
| NCT00019578 |
Stereotactic Radiosurgery in Treating Patients With Brain Tumors |
https://ClinicalTrials.gov/show/NCT00019578 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00431561 |
Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade Glioma |
https://ClinicalTrials.gov/show/NCT00431561 |
Completed |
Isarna Therapeutics GmbH |
2009-03-31 |
| NCT00430911 |
Radiotherapy for Malignant Astrocytomas in the Elderly |
https://ClinicalTrials.gov/show/NCT00430911 |
Completed |
Assistance Publique - Hôpitaux de Paris |
NA |
| NCT00411619 |
Everolimus (RAD001) Therapy of Giant Cell Astrocytoma in Patients With Tuberous Sclerosis Complex |
https://ClinicalTrials.gov/show/NCT00411619 |
Completed |
Children’s Hospital Medical Center, Cincinnati |
2014-01-31 |
| NCT00409214 |
Phase IIa Safety and Light Dose-escalation Study in Patients With Primary or Recurrent/High-grade Glioma Using the Litxâ„¢ System to Confirm the Zone of Tumor Destruction During the Intraoperative Treatment of Glioma |
https://ClinicalTrials.gov/show/NCT00409214 |
Completed |
Light Sciences Oncology |
2008-02-29 |
| NCT00392171 |
The Effects of Continuous 28-day (28/28) Temozolomide Chemotherapy in Subjects With Recurrent Malignant Glioma Who Have Failed the Conventional 5-day (5/28) Treatment (P04601) |
https://ClinicalTrials.gov/show/NCT00392171 |
Completed |
Merck Sharp & Dohme Corp. |
2009-09-15 |
| NCT00390299 |
Viral Therapy in Treating Patients With Recurrent Glioblastoma Multiforme |
https://ClinicalTrials.gov/show/NCT00390299 |
Completed |
Mayo Clinic |
2018-11-29 |
| NCT00381797 |
Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma |
https://ClinicalTrials.gov/show/NCT00381797 |
Completed |
National Cancer Institute (NCI) |
2015-10-31 |
| NCT00369590 |
VEGF Trap in Treating Patients With Recurrent Malignant Gliomas That Did Not Respond to Temozolomide |
https://ClinicalTrials.gov/show/NCT00369590 |
Completed |
National Cancer Institute (NCI) |
2011-12-31 |
| NCT00363272 |
Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma |
https://ClinicalTrials.gov/show/NCT00363272 |
Completed |
National Cancer Institute (NCI) |
2008-10-31 |
| NCT00362570 |
Temozolomide in Patients With Newly Diagnosed Anaplastic Oligodendroglioma and Mixed Oligoastrocytoma |
https://ClinicalTrials.gov/show/NCT00362570 |
Completed |
Ohio State University Comprehensive Cancer Center |
2007-04-30 |
| NCT00335075 |
Efficacy and Safety of Temodal vs Semustine in Subjects With Recurrent Glioblastoma or Anaplastic Astrocytoma (Study P03644) |
https://ClinicalTrials.gov/show/NCT00335075 |
Completed |
Merck Sharp & Dohme Corp. |
2006-02-23 |
| NCT00326664 |
AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors |
https://ClinicalTrials.gov/show/NCT00326664 |
Completed |
National Cancer Institute (NCI) |
2015-07-31 |
| NCT00301418 |
Oral Tarceva Study for Recurrent/Residual Glioblastoma Multiforme and Anaplastic Astrocytoma |
https://ClinicalTrials.gov/show/NCT00301418 |
Completed |
Northwell Health |
2014-05-31 |
| NCT00268385 |
Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas |
https://ClinicalTrials.gov/show/NCT00268385 |
Active, not recruiting |
National Cancer Institute (NCI) |
2011-10-15 |
| NCT00165360 |
Prolonged Daily Temozolomide for Low-Grade Glioma |
https://ClinicalTrials.gov/show/NCT00165360 |
Completed |
Dana-Farber Cancer Institute |
2006-12-31 |
| NCT00154375 |
Study of Imatinib Mesylate in Combination With Hydroxyurea Versus Hydroxyurea Alone as an Oral Therapy in Patients With Temozolomide Resistant Progressive Glioblastoma |
https://ClinicalTrials.gov/show/NCT00154375 |
Completed |
Novartis |
2008-08-31 |
| NCT00115440 |
BNCT to Treat Glioma That Has Progressed Following Radiotherapy |
https://ClinicalTrials.gov/show/NCT00115440 |
Completed |
Boneca Corporation |
2008-12-31 |
| NCT00101270 |
Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas |
https://ClinicalTrials.gov/show/NCT00101270 |
Completed |
National Cancer Institute (NCI) |
2007-09-30 |
| NCT00100880 |
Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors |
https://ClinicalTrials.gov/show/NCT00100880 |
Completed |
National Cancer Institute (NCI) |
2010-11-30 |
| NCT00095940 |
Lapatinib in Treating Young Patients With Recurrent or Refractory Central Nervous System Tumors |
https://ClinicalTrials.gov/show/NCT00095940 |
Completed |
National Cancer Institute (NCI) |
2010-07-31 |
| NCT00093613 |
Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma |
https://ClinicalTrials.gov/show/NCT00093613 |
Completed |
National Cancer Institute (NCI) |
2010-10-31 |
| NCT00003775 |
Leflunomide in Treating Patients With Anaplastic Astrocytoma in First Relapse |
https://ClinicalTrials.gov/show/NCT00003775 |
Completed |
Pfizer |
2006-05-31 |
| NCT00091182 |
Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment |
https://ClinicalTrials.gov/show/NCT00091182 |
Completed |
National Cancer Institute (NCI) |
2006-02-28 |
| NCT00089427 |
IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma |
https://ClinicalTrials.gov/show/NCT00089427 |
Completed |
INSYS Therapeutics Inc |
2007-07-31 |
| NCT00085540 |
FR901228 in Treating Patients With Recurrent High-Grade Gliomas |
https://ClinicalTrials.gov/show/NCT00085540 |
Completed |
National Cancer Institute (NCI) |
2008-12-31 |
| NCT00003621 |
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Anaplastic Astrocytoma |
https://ClinicalTrials.gov/show/NCT00003621 |
Completed |
Alliance for Clinical Trials in Oncology |
2005-02-28 |
| NCT00002463 |
Combination Chemotherapy in Treating Children With Astrocytomas and Primitive Neuroectodermal Tumors |
https://ClinicalTrials.gov/show/NCT00002463 |
Completed |
M.D. Anderson Cancer Center |
2007-01-31 |
| NCT00080054 |
A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas |
https://ClinicalTrials.gov/show/NCT00080054 |
Completed |
Pharmacyclics LLC. |
NA |
| NCT00077454 |
Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid Tumors |
https://ClinicalTrials.gov/show/NCT00077454 |
Completed |
National Cancer Institute (NCI) |
2007-09-30 |
| NCT00064779 |
Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recurrent Malignant Glioma |
https://ClinicalTrials.gov/show/NCT00064779 |
Completed |
INSYS Therapeutics Inc |
2006-06-30 |
| NCT00063973 |
Cilengitide in Treating Children With Refractory Primary Brain Tumors |
https://ClinicalTrials.gov/show/NCT00063973 |
Completed |
National Cancer Institute (NCI) |
2008-03-31 |
| NCT00004868 |
SU5416 in Treating Patients With Recurrent Astrocytoma or Mixed Glioma That Has Not Responded to Radiation Therapy |
https://ClinicalTrials.gov/show/NCT00004868 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2004-09-15 |
| NCT00053963 |
FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia |
https://ClinicalTrials.gov/show/NCT00053963 |
Completed |
National Cancer Institute (NCI) |
2006-02-28 |
| NCT00004078 |
Irinotecan in Treating Children With Refractory Solid Tumors |
https://ClinicalTrials.gov/show/NCT00004078 |
Completed |
Children’s Oncology Group |
2007-10-31 |
| NCT00052780 |
Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors |
https://ClinicalTrials.gov/show/NCT00052780 |
Completed |
National Cancer Institute (NCI) |
2007-11-30 |
| NCT00045708 |
A Phase I/II Trial of BMS-247550 for Treatment of Patients With Recurrent High-Grade Gliomas |
https://ClinicalTrials.gov/show/NCT00045708 |
Completed |
National Cancer Institute (NCI) |
2010-05-31 |
| NCT00045110 |
Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma |
https://ClinicalTrials.gov/show/NCT00045110 |
Completed |
National Cancer Institute (NCI) |
2010-12-31 |
| NCT00030498 |
Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction |
https://ClinicalTrials.gov/show/NCT00030498 |
Completed |
National Cancer Institute (NCI) |
2007-07-31 |
| NCT00025675 |
Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors |
https://ClinicalTrials.gov/show/NCT00025675 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2006-07-05 |
| NCT00012181 |
Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas |
https://ClinicalTrials.gov/show/NCT00012181 |
Completed |
National Cancer Institute (NCI) |
2005-01-31 |
| NCT00004259 |
Radiation Therapy Combined With Chemotherapy in Treating Patients With Anaplastic Astrocytoma or Mixed Gliomas |
https://ClinicalTrials.gov/show/NCT00004259 |
Completed |
Radiation Therapy Oncology Group |
2015-02-01 |
| NCT00004024 |
Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma |
https://ClinicalTrials.gov/show/NCT00004024 |
Completed |
Barbara Ann Karmanos Cancer Institute |
2004-01-31 |
| NCT00004017 |
Radiolabeled Monoclonal Antibody in Treating Patients With Glioblastoma Multiforme or Anaplastic Astrocytoma |
https://ClinicalTrials.gov/show/NCT00004017 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00003537 |
Antineoplaston Therapy in Treating Adult Patients With Anaplastic Astrocytoma |
https://ClinicalTrials.gov/show/NCT00003537 |
Completed |
Burzynski Research Institute |
2008-10-31 |
| NCT00003470 |
Antineoplaston Therapy in Treating Patients With Anaplastic Astrocytoma |
https://ClinicalTrials.gov/show/NCT00003470 |
Completed |
Burzynski Research Institute |
2008-12-31 |
| NCT00003468 |
Antineoplaston Therapy in Treating Children With Low-Grade Astrocytoma |
https://ClinicalTrials.gov/show/NCT00003468 |
Completed |
Burzynski Research Institute |
2004-07-31 |
| NCT00002944 |
Combination Chemotherapy in Treating Children With Progressive Brain Tumors |
https://ClinicalTrials.gov/show/NCT00002944 |
Completed |
Children’s Oncology Group |
2006-02-28 |
| NCT00041587 |
Pre-operative IL13-PE38QQR in Patients With Recurrent or Progressive Malignant Glioma |
https://ClinicalTrials.gov/show/NCT00041587 |
Completed |
INSYS Therapeutics Inc |
2006-06-30 |
| NCT00795457 |
Effects of Vaccinations With HLA-A2-Restricted Glioma Antigen-Peptides in Combination With Poly-ICLC for Adults With High-Risk WHO Grade II Astrocytomas and Oligo-Astrocytomas |
https://ClinicalTrials.gov/show/NCT00795457 |
Completed |
University of Pittsburgh |
2013-02-28 |
| NCT00028158 |
Safety and Effectiveness Study of G207, a Tumor-Killing Virus, in Patients With Recurrent Brain Cancer |
https://ClinicalTrials.gov/show/NCT00028158 |
Completed |
MediGene |
NA |
| NCT00112736 |
Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma |
https://ClinicalTrials.gov/show/NCT00112736 |
Completed |
National Cancer Institute (NCI) |
2010-04-30 |
| NCT00028795 |
Chemotherapy and Radiation Therapy After Surgery in Treating Children With Newly Diagnosed Astrocytoma, Glioblastoma Multiforme, Gliosarcoma, or Diffuse Intrinsic Pontine Glioma |
https://ClinicalTrials.gov/show/NCT00028795 |
Completed |
Children’s Oncology Group |
2007-09-30 |
| NCT00024570 |
Interstitial Infusion of IL13-PE38QQR Cytotoxin in Recurrent Malignant Glioma |
https://ClinicalTrials.gov/show/NCT00024570 |
Completed |
INSYS Therapeutics Inc |
2007-07-31 |
| NCT00024557 |
Histologic Effect/Safety of Pre/Post-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant Glioma Patients |
https://ClinicalTrials.gov/show/NCT00024557 |
Completed |
INSYS Therapeutics Inc |
2006-06-30 |
| NCT00042991 |
Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas |
https://ClinicalTrials.gov/show/NCT00042991 |
Completed |
National Cancer Institute (NCI) |
2010-02-28 |
| NCT00008008 |
Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant Glioma |
https://ClinicalTrials.gov/show/NCT00008008 |
Completed |
National Cancer Institute (NCI) |
2005-06-30 |
| NCT00070525 |
Tipifarnib in Treating Young Patients With Recurrent or Progressive High-Grade Glioma, Medulloblastoma, Primitive Neuroectodermal Tumor, or Brain Stem Glioma |
https://ClinicalTrials.gov/show/NCT00070525 |
Completed |
National Cancer Institute (NCI) |
2006-09-30 |
| NCT00004688 |
Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms |
https://ClinicalTrials.gov/show/NCT00004688 |
Completed |
FDA Office of Orphan Products Development |
NA |